Loading...
Celanese Corporation
CE•NYSE
Basic MaterialsChemicals
$55.48
$0.95(1.75%)
Celanese Corporation (CE) Financial Performance & Statements
Review Celanese Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-6.03%
↓ 6.03%
Operating Income Growth
-141.32%
↓ 141.32%
Net Income Growth
-177.65%
↓ 177.65%
Operating Cash Flow Growth
-49.13%
↓ 49.13%
Operating Margin
-6.64%
↓ 6.64%
Gross Margin
22.65%
↑ 22.65%
Net Profit Margin
-16.54%
↓ 16.54%
ROE
-26.84%
↓ 26.84%
ROIC
-3.27%
↓ 3.27%
Celanese Corporation (CE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Celanese Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.37B | $2.65B | $2.65B | $2.61B |
| Cost of Revenue | $1.83B | $2.03B | $2.04B | $2.10B |
| Gross Profit | $539.00M | $622.00M | $609.00M | $516.00M |
| Gross Profit Ratio | $0.23 | $0.23 | $0.23 | $0.20 |
| R&D Expenses | $31.00M | $32.00M | $33.00M | $34.00M |
| SG&A Expenses | $262.00M | $248.00M | $255.00M | $265.00M |
| Operating Expenses | $1.94B | $280.00M | $288.00M | $299.00M |
| Total Costs & Expenses | $3.77B | $2.40B | $2.33B | $2.39B |
| Interest Income | $5.00M | $5.00M | $10.00M | $13.00M |
| Interest Expense | $164.00M | $169.00M | $174.00M | $169.00M |
| Depreciation & Amortization | $184.00M | $187.00M | $198.00M | $227.00M |
| EBITDA | -$1.17B | $539.00M | $555.00M | $553.00M |
| EBITDA Ratio | -$0.49 | $0.20 | $0.21 | $0.21 |
| Operating Income | -$1.41B | $248.00M | $321.00M | $217.00M |
| Operating Income Ratio | -$0.59 | $0.09 | $0.12 | $0.08 |
| Other Income/Expenses (Net) | -$114.00M | -$65.00M | -$138.00M | -$53.00M |
| Income Before Tax | -$1.52B | $183.00M | $183.00M | $157.00M |
| Income Before Tax Ratio | -$0.64 | $0.07 | $0.07 | $0.06 |
| Income Tax Expense | $387.00M | $61.00M | $29.00M | $33.00M |
| Net Income | -$1.91B | $116.00M | $155.00M | $121.00M |
| Net Income Ratio | -$0.81 | $0.04 | $0.06 | $0.05 |
| EPS | -$17.50 | $1.06 | $1.42 | $1.11 |
| Diluted EPS | -$17.50 | $1.06 | $1.41 | $1.11 |
| Weighted Avg Shares Outstanding | $109.40M | $109.34M | $109.31M | $109.10M |
| Weighted Avg Shares Outstanding (Diluted) | $109.40M | $109.50M | $109.55M | $109.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan